Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

VKTXVKTX
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in VIKING THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 942,841 shares of VKTX (VIKING THERAPEUTICS INC), worth $36.8M as of 2026-Q2. The position was decreased (-1.9% shares). VKTX represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$36.8M

Current Shares

942,841

Total Value Change

+$32.7M

Total Shares Change

+841,139

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
942,841
-1.9%
$36.8M0.0%$39.01
0
2026-Q1
Increased
960,570
+15.4%
$31.3M0.0%$31.93
33
2025-Q4
Increased
832,651
+211.0%
$29.3M0.0%$35.32
46
2025-Q3
Increased
267,744
+74.5%
$7M0.0%$25.81
41
2025-Q2
Increased
153,418
+10.1%
$4.1M0.0%$26.52
29
2025-Q1
Increased
139,355
+37.0%
$3.4M0.0%$25.65
35
2024-Q4
New
101,702
-
$4.1M0.0%$39.77
37

Other major holders of VKTX: BlackRock Finance, Inc., FMR LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used